Ata uhi

Sigma-1 Receptor Plays a Negative Modulation on N-type Calcium Channel

The sigma-1 receptor is a 223 amino acids molecular chaperone with a single transmembrane domain. It is resident to eukaryotic mitochondrial-associated endoplasmic reticulum and plasma membranes. By chaperone-mediated interactions with ion channels, G-protein coupled receptors and cell-signaling mol...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Kang Zhang (Author), Zhe Zhao (Author), Liting Lan (Author), Xiaoli Wei (Author), Liyun Wang (Author), Xiaoyan Liu (Author), Haitao Yan (Author), Jianquan Zheng (Author)
Hōputu:	Pukapuka
I whakaputaina:	Frontiers Media S.A., 2017-05-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function
mā: Alba Vera-Zambrano, me ētahi atu.
I whakaputaina: (2023)

Molecular Interplay Between the Sigma-1 Receptor, Steroids, and Ion Channels
mā: Sara L. Morales-Lázaro, me ētahi atu.
I whakaputaina: (2019)

Allosteric Modulators of Sigma-1 Receptor: A Review
mā: Edijs Vavers, me ētahi atu.
I whakaputaina: (2019)

Sigma Receptors
I whakaputaina: (2020)

Editorial: Sigma Receptors
mā: Ebru Aydar, me ētahi atu.
I whakaputaina: (2020)

The Role of Sigma Receptors in Depression
mā: Jordanna E. Bermack, me ētahi atu.
I whakaputaina: (2005)

Sigma-1 receptor and seizures
mā: Edijs Vavers, me ētahi atu.
I whakaputaina: (2023)

Role of Sigma Receptors in Alcohol Addiction
mā: Sema G. Quadir, me ētahi atu.
I whakaputaina: (2019)

Role of sigma-1 receptors in neurodegenerative diseases
mā: Linda Nguyen, me ētahi atu.
I whakaputaina: (2015)

The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration
mā: Karsten Ruscher, me ētahi atu.
I whakaputaina: (2015)

Sigma Receptors as Endoplasmic Reticulum Stress "Gatekeepers" and their Modulators as Emerging New Weapons in the Fight Against Cancer
mā: Anna Tesei, me ētahi atu.
I whakaputaina: (2018)

T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions
mā: Maricruz Rangel-Galván, me ētahi atu.
I whakaputaina: (2023)

Negative Impact of Sigma-1 Receptor Agonist Treatment on Tissue Integrity and Motor Function Following Spinal Cord Injury
mā: Alise Lattard, me ētahi atu.
I whakaputaina: (2021)

Ligands Exert Biased Activity to Regulate Sigma 1 Receptor Interactions With Cationic TRPA1, TRPV1, and TRPM8 Channels
mā: Elsa Cortés-Montero, me ētahi atu.
I whakaputaina: (2019)

Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development
mā: Peng Ren, me ētahi atu.
I whakaputaina: (2022)

Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes
mā: Halley M. Oyer, me ētahi atu.
I whakaputaina: (2019)

PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti-SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships
mā: Carmen Abate, me ētahi atu.
I whakaputaina: (2020)

Type of Electrical Stimulation Influences Diaphragm Response to Adrenoceptor and Calcium Channel Modulators: the Role of Extracellular and Intracellular Calcium Events
mā: Zoran Todorovic, me ētahi atu.
I whakaputaina: (2006)

Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
mā: Timur A. Mavlyutov, me ētahi atu.
I whakaputaina: (2015)

A Perspective on sigma-1 receptor research: Past and future
mā: Tsung-Ping Su
I whakaputaina: (2015)

Inhibitory effects of sigma-2 receptor agonists on T lymphocyte activation
mā: Miguel Angel Iñiguez, me ētahi atu.
I whakaputaina: (2013)

Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs
mā: Teruo Hayashi
I whakaputaina: (2015)

Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
mā: José Miguel Vela
I whakaputaina: (2020)

A Role for Sigma Receptors in Stimulant Self Administration and Addiction
mā: Shang-Yi Tsai, me ētahi atu.
I whakaputaina: (2011)

Hazards of Using Masking Protocols When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 Receptors
mā: Haider Abbas, me ētahi atu.
I whakaputaina: (2020)

Modulation of Transient Receptor Potential C Channel Activity by Cholesterol
mā: Rita Gutorov, me ētahi atu.
I whakaputaina: (2019)

Calcium Channel Antagonist Toxicity
mā: Elaine Fielder, me ētahi atu.
I whakaputaina: (2014)

Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer
mā: Anna Tesei, me ētahi atu.
I whakaputaina: (2019)

Clinical features of neuromuscular disorders in patients with N-type voltage-gated calcium channel antibodies
mā: Andreas Totzeck, me ētahi atu.
I whakaputaina: (2016)

Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers
mā: Steffi A. Maria, MD, me ētahi atu.
I whakaputaina: (2023)

Modulation by Sigma-1 Receptor of Morphine Analgesia and Tolerance: Nociceptive Pain, Tactile Allodynia and Grip Strength Deficits During Joint Inflammation
mā: Ángeles Montilla-García, me ētahi atu.
I whakaputaina: (2019)

Ion channel-mediated mitochondrial volume regulation and its relationship with mitochondrial dynamics
mā: Yujia Zhuang, me ētahi atu.
I whakaputaina: (2024)

Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET)
mā: Yu Lan, me ētahi atu.
I whakaputaina: (2019)

Calcium Channel Blocker Overdose Simulation
mā: Michael Maniaci, me ētahi atu.
I whakaputaina: (2015)

Discovery and Development of Calcium Channel Blockers
mā: Théophile Godfraind
I whakaputaina: (2017)

Calcium Permeable Channels in Cancer Hallmarks
mā: Sendoa Tajada, me ētahi atu.
I whakaputaina: (2020)

Identification of a Novel EF-Loop in the N-terminus of TRPM2 Channel Involved in Calcium Sensitivity
mā: Yuhuan Luo, me ētahi atu.
I whakaputaina: (2018)

Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists
mā: Fa-Wu Dong, me ētahi atu.
I whakaputaina: (2018)

N-type calcium channel blockers: a new approach towards the treatment of chronic neuropathic pain
mā: Shikha Choudhary, me ētahi atu.
I whakaputaina: (2023)

Role of L-, N- and T-type Calcium Channels in Achieving Maximum Analgesic and Minimum Toxic Effect of Tramadol
mā: Mehmet Yilmaz, me ētahi atu.
I whakaputaina: (2024)